These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial-mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis. Lee YJ; Park KS; Heo SH; Nam HS; Cho MK; Lee SH Arch Pharm Res; 2019 Oct; 42(10):890-901. PubMed ID: 31428976 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma. Laaksonen S; Kettunen E; Sutinen E; Ilonen I; Vehmas T; Törmäkangas T; Räsänen J; Wolff H; Myllärniemi M J Thorac Oncol; 2022 Aug; 17(8):1032-1041. PubMed ID: 35367351 [TBL] [Abstract][Full Text] [Related]
26. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects. Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567 [TBL] [Abstract][Full Text] [Related]
27. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure. Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176 [TBL] [Abstract][Full Text] [Related]
28. Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma. Digifico E; Erreni M; Mannarino L; Marchini S; Ummarino A; Anfray C; Bertola L; Recordati C; Pistillo D; Roncalli M; Bossi P; Zucali PA; D'Incalci M; Belgiovine C; Allavena P Front Immunol; 2023; 14():1116430. PubMed ID: 37398648 [TBL] [Abstract][Full Text] [Related]
29. Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor requires E-cadherin in esophageal cancer and malignant pleural mesothelioma. Xin HW; Yang JH; Nguyen DM Anticancer Res; 2013 Jun; 33(6):2401-8. PubMed ID: 23749888 [TBL] [Abstract][Full Text] [Related]
30. NF2 blocks Snail-mediated p53 suppression in mesothelioma. Cho JH; Lee SJ; Oh AY; Yoon MH; Woo TG; Park BJ Oncotarget; 2015 Apr; 6(12):10073-85. PubMed ID: 25823924 [TBL] [Abstract][Full Text] [Related]
31. Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report. Almeida GC; Santos UP; Parente YDM; Colares PFB; Mizutani RF; Bernardi FDC; Terra RM; Terra-Filho M Am J Ind Med; 2022 Jul; 65(7):620-623. PubMed ID: 35524457 [TBL] [Abstract][Full Text] [Related]
32. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154 [TBL] [Abstract][Full Text] [Related]
34. CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. Jamal S; Cheriyan VT; Muthu M; Munie S; Levi E; Ashour AE; Pass HI; Wali A; Singh M; Rishi AK PLoS One; 2014; 9(3):e89146. PubMed ID: 24598827 [TBL] [Abstract][Full Text] [Related]
35. Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework. Bozzi F; Brich S; Dagrada GP; Negri T; Conca E; Cortelazzi B; Belfiore A; Perrone F; Gualeni AV; Gloghini A; Cabras A; Brenca M; Maestro R; Zaffaroni N; Casali P; Bertulli R; Deraco M; Pilotti S Oncotarget; 2016 Nov; 7(46):75503-75517. PubMed ID: 27705913 [TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic features of erionite-induced malignant mesothelioma. Demirer E; Ghattas CF; Radwan MO; Elamin EM Yonsei Med J; 2015 Mar; 56(2):311-23. PubMed ID: 25683976 [TBL] [Abstract][Full Text] [Related]
37. ATG5 as biomarker for early detection of malignant mesothelioma. Tomasetti M; Monaco F; Strogovets O; Volpini L; Valentino M; Amati M; Neuzil J; Santarelli L BMC Res Notes; 2023 Apr; 16(1):61. PubMed ID: 37095543 [TBL] [Abstract][Full Text] [Related]
38. IL-7 is expressed in malignant mesothelioma and has a prognostic value. Mai HL; Deshayes S; Nguyen TV; Dehame V; Chéné AL; Brouard S; Blanquart C Mol Oncol; 2022 Oct; 16(20):3606-3619. PubMed ID: 36054746 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia. Alì G; Borrelli N; Riccardo G; Proietti A; Pelliccioni S; Niccoli C; Boldrini L; Lucchi M; Mussi A; Fontanini G J Thorac Oncol; 2013 Nov; 8(11):1389-95. PubMed ID: 24084442 [TBL] [Abstract][Full Text] [Related]
40. Interleukin-8 induction by Helicobacter pylori in gastric epithelial cells is dependent on apurinic/apyrimidinic endonuclease-1/redox factor-1. O'Hara AM; Bhattacharyya A; Mifflin RC; Smith MF; Ryan KA; Scott KG; Naganuma M; Casola A; Izumi T; Mitra S; Ernst PB; Crowe SE J Immunol; 2006 Dec; 177(11):7990-9. PubMed ID: 17114472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]